Paper Title

AMIFAMPRIDINE PHOSPHATE : AN OVERVIEW

Authors

Dr.D.NAGAVALLI , P.NANTHAGOPAL

Keywords

Amifampridine Phosphate( FIRDAPSE) , Lambert–Eaton myasthenic syndrome(LEMS),Blocking potassium channel efflux, Neuro Muscular Junctions (NMJs).

Abstract

Amifampridine is used to treat many of the congenital myasthenic syndromes, particularly those with defects in choline acetyltransferase, downstream kinase 7, and those where any kind of defect causes "fast channel" behaviour of the acetylcholine receptor. It is also used to treat symptoms of Lambert–Eaton myasthenic syndrome Amifampridine, or 3,4-diaminopyridine (3,4-DAP), is a quaternary ammonium compound that blocks presynaptic potassium channels, and subsequently prolongs the action potential and increases presynaptic calcium concentrations. LEMS is a rare auto-immune disorder of the neuromuscular junction that is characterized by proximal muscle weakness, depressed tendon reflexes, and posttetanic potentiation in addition to autonomic dysfunction. Amifampridine improves muscle strength and resting compound muscle action potential (CMAP). Amifampridine phosphate is a more stable salt that serves as an active ingredient of EMA-approved Firdapse, which was previously marketed as Zenas. . Amifampridine is the nonimmune treatment options for LEMS. In phase III clinical trials of adult patients with LEMS, treatment of amifampridine significantly improved symptoms of LEMS compared to placebo with good tolerance. Amifampridine is indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients.

How To Cite

"AMIFAMPRIDINE PHOSPHATE : AN OVERVIEW", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.8, Issue 6, page no.155 - 165, June-2023, Available :https://ijsdr.org/papers/IJSDR2306027.pdf

Issue

Volume 8 Issue 6, June-2023

Pages : 155 - 165

Other Publication Details

Paper Reg. ID: IJSDR_207017

Published Paper Id: IJSDR2306027

Downloads: 000347263

Research Area: Pharmacy

Country: Chengalpattu, Tamilnadu, India

Published Paper PDF: https://ijsdr.org/papers/IJSDR2306027

Published Paper URL: https://ijsdr.org/viewpaperforall?paper=IJSDR2306027

About Publisher

ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJSDR(IJ Publication) Janvi Wave

Article Preview

academia
publon
sematicscholar
googlescholar
scholar9
maceadmic
Microsoft_Academic_Search_Logo
elsevier
researchgate
ssrn
mendeley
Zenodo
orcid
sitecreex